Skip to main content
Premium Trial:

Request an Annual Quote

North Carolina Researchers Receive State Grant to Develop Ultra High-Density Arrays


The North Carolina Biotechnology Center has awarded its first-ever multidisciplinary research grant to researchers at Duke University and the University of North Carolina at Chapel Hill to develop “ultradense” oligonucleotide arrays, in collaboration with Xanthon, a North Carol -ina microarray startup.

Michael Pirrung, a chemistry professor at Duke, and Holden Thorp, a chemistry professor at UNC Chapel Hill, will direct research under the grant.

Pirrung and Thorp have been developing electrochemical detection methods for arrays that could enable the arrays to include up to 10 million electrodes per square centimeter.

“With high density arrays, there are now feature size limits on how small a spot one could detect a signal from,” said Pirrung. “If you want to have valid data points on an array with sub-micron features, it would be almost impossible to detect at that level” with chemiluminescent detection methods. “Very small electrodes and electrochemical detection techniques can detect tiny features,” he said.

As a condition of receiving the grant, Pirrung and Holden had to show that the technology could be commercialized feasibly, according to Pirrung. One criticism that reviewers had was the surface chemistry on the arrays. The model in the grant proposal involved gold and sulfur binding chemistry, and critics raised questions about the stability of this bond. But since then, the researchers have gone back to the drawing board and developed chemistries that they knew were more stable.

Xanthon plans to refine methods to manufacture these arrays on a large-scale basis — MMJ

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.